Ameriprise
BNTC icon

Ameriprise’s Benitec Biopharma BNTC Stock Holding History

Ameriprise’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.37M Sell
401,245
-7,525
-2% -$89.3K ﹤0.01% 2497
2026
Q1 		$4.35M Buy
408,770
+128,043
+46% +$1.48M ﹤0.01% 2527
2025
Q4 		$3.78M Buy
280,727
+126,313
+82% +$1.75M ﹤0.01% 2626
2025
Q3 		$2.17M Buy
154,414
+44,489
+40% +$568K ﹤0.01% 2961
2025
Q2 		$1.29M Buy
109,925
+75,507
+219% +$1.06M ﹤0.01% 3159
2025
Q1 		$448K Sell
34,418
-1,058
-3% -$12.8K ﹤0.01% 3531
2024
Q4 		$448K Buy
35,476
+20,597
+138% +$222K ﹤0.01% 3562
2024
Q3 		$137K Buy
+14,879
New +$133K ﹤0.01% 3798

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Ameriprise's BNTC Position: Q2 2026 in Review

Ameriprise reduced its Benitec Biopharma (BNTC) stake by 1.8% in Q2 2026, selling an estimated $89.3K and leaving 401,245 shares worth $5.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2497.

Ameriprise first reported a position in BNTC in Q3 2024 and has held it in 8 quarters since. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Ameriprise held 401,245 shares of Benitec Biopharma worth $5.37M as of Q2 2026.
  • Ameriprise sold 7,525 Benitec Biopharma shares in Q2 2026, an estimated $89.3K.
  • Benitec Biopharma made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2497 holding.
  • Ameriprise first reported a position in Benitec Biopharma in Q3 2024 and has held it in 8 quarters since.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.